INCYTE-‍UNDER AGREEMENT, SYROS TO USE ITS GENE CONTROL PLATFORM ... CO TO PAY SYROS $10 …
Sixteen analysts surveyed by Zacks expected $360.2 million. Incyte shares have climbed 14 percent since the beginning of the year. The stock has risen 31 percent in the last 12 months. This story was generated by Automated Insights (http ...
symbol=GILD Wilmington, Delaware headquartered Incyte Corp.'s shares closed the day 0.99% higher at $94.08. The …
Today we're going to take a look at the well-established Incyte Corporation (NASDAQ:INCY). The company's stock See our latest analysis for INCY INCY appears to be overvalued according to my relative valuation model. In this instance, I’ve …
Jan 31 (Reuters) - Incyte Corp: * SYROS PHARMACEUTICALS -‍ ON JAN 31, ENTERED AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT WITH INCYTE TO FACILITATE PRIVATE PLACEMENT - SEC FILING * SYROS …
Sixteen analysts surveyed by Zacks expected $360.2 million. Incyte shares have climbed 14 percent since the beginning of the year. The stock has risen 31 percent in the last 12 months. This story was generated by Automated Insights (http ...
Yahoo!7mon